Contemporary Issues in Lung CancerJones & Bartlett Publishers, 2009 M02 12 - 364 pages In the United States, lung cancer is the second most commonly diagnosed cancer and the leading cause of cancer death. Even more devastating is its five-year survival rate of only 15.8%. Despite these dismal facts, lung cancer receives little national attention and research and funding for lung cancer lags behind other cancers. The intent of Contemporary Issues in Lung Cancer: A Nursing Perspective Second Edition is to provide oncology nurses and healthcare professionals with in-depth information on the issues that surround this disease, so that they might impact both education and research and provide better care for their patients. |
From inside the book
Results 1-5 of 68
Page 17
... potential gene and genome ap- proaches for early detection of lung cancer, as well as potential new therapies. Over the past years, it has become clinically evident that there are nu- merous clonal genetic and epigenetic alternations ...
... potential gene and genome ap- proaches for early detection of lung cancer, as well as potential new therapies. Over the past years, it has become clinically evident that there are nu- merous clonal genetic and epigenetic alternations ...
Page 18
... potential • Sustained angiogenesis • Tissue invasion and metastases Given that current therapies have had limited impact upon survival rates for lung cancer, it is imperative that we search for other options. With this new knowledge ...
... potential • Sustained angiogenesis • Tissue invasion and metastases Given that current therapies have had limited impact upon survival rates for lung cancer, it is imperative that we search for other options. With this new knowledge ...
Page 21
... potential cancer treatment (see Table 2–1). Evading. Apoptosis. Apoptosis is programmed cell death, usually due to a physiologic process. Cancer cells have acquired a mechanism to avoid apoptosis. The impact of avoiding apoptosis affects ...
... potential cancer treatment (see Table 2–1). Evading. Apoptosis. Apoptosis is programmed cell death, usually due to a physiologic process. Cancer cells have acquired a mechanism to avoid apoptosis. The impact of avoiding apoptosis affects ...
Page 23
... potential pathway to avoid apoptosis is through 1 integrin-stimulated tyrosine kinase activation. Also, Fas (CD95) and its ligand (FasL) are implicated in avoiding apoptosis (Sekido, et al., 2005). Insensitivity. to. Antigrowth. Signals ...
... potential pathway to avoid apoptosis is through 1 integrin-stimulated tyrosine kinase activation. Also, Fas (CD95) and its ligand (FasL) are implicated in avoiding apoptosis (Sekido, et al., 2005). Insensitivity. to. Antigrowth. Signals ...
Page 24
... potential targets are TSLC1, which is located at 11q23, and MYO18B at 22q12 (Sekido, et al., 2005). The frequent ... potential areas in the development or promotion of lung cancer. One area identified, 3p21.3, has been noted to have ...
... potential targets are TSLC1, which is located at 11q23, and MYO18B at 22q12 (Sekido, et al., 2005). The frequent ... potential areas in the development or promotion of lung cancer. One area identified, 3p21.3, has been noted to have ...
Contents
Oncology Treatment Modalities | 45 |
Special Issues Facing Individuals with Lung Cancer | 117 |
Psychosocial Issues of Individuals with Lung Cancer | 231 |
Assistance and Resources for Individuals Facing Lung Cancer | 255 |
Media and Future Research Directions | 301 |
Index | 353 |
Other editions - View all
Common terms and phrases
adjuvant agents aprepitant associated bevacizumab breathing breathlessness Bruera carboplatin carcinoma cell lung cancer chemotherapy chronic cisplatin Clinical Oncology clinical trials combination diagnosis disease docetaxel dose drug dyspnea EGFR erlotinib etoposide evaluation evidence-based factors fatigue gefitinib gemcitabine gene improve increased individuals indoor radon Internet intervention irinotecan Journal of Clinical lung cancer patients Medicine ment metastatic months NCCN nicotine non-small cell lung NSCLC Nursing Forum Oncology Nursing Oncology Nursing Forum paclitaxel palliative palliative care patient navigation patients and families patients with lung pemetrexed phase potential pulmonary quit smoking radiation therapy radiotherapy radon randomized receptors regimen reported resection respiratory response rate risk role SCLC score screening Sekido side effects small cell lung smoking cessation stage strategies support group surgical survival rate Symptom Management Table tients tion tobacco topotecan toxicity treat treatment tumor versus vinorelbine weight loss